You have no items in your shopping cart.
Cynomolgus FGF-21 [orb3002238]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.2 KDa. Observed: 19-24 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human FGFb [orb3002364]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KGF [orb3002371]
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 20 KDa. Observed: 20-27 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse FGF-21 [orb3002387]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.8 KDa. Observed: 20-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-21 [orb3002405]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 21.69 KDa. Observed: 23 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-4 [orb3002445]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.9 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human/Mouse FGF-8b [orb3002449]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.5 KDa. Observed: 23 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-12 [orb3002303]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.45 KDa. Observed: 19 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse FGF-9 [orb3002305]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.4 KDa. Observed: 25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-9 [orb3002310]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.44 KDa. Observed: 25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg